Neurentis PLC
Last updated September 28, 2026
Organization details
- Legal name
- Neurentis PLC
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 21100 - Manufacture of basic pharmaceutical products
- Year founded
- 2022
- Jurisdiction of incorporation
- England and Wales
- Headquarters city
- London
- Headquarters country
- United Kingdom
- Fiscal year end
- November
Identifiers
- UK company number
- 14461527
Board of directors
-
Bijoy Kumar Premi · DirectorSince 2022
-
Dimitri Dimitriou · DirectorSince 2023
-
Stephane Robert Georges, Mery · DirectorSince 2023
Former directors
-
Franco Di Muzio · Director2022 – 2023
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Akanda Corp.
Nasdaq: AKAN · New Romney, United Kingdom
Organization
Akari Therapeutics plc
Nasdaq: AKTX · Tampa, United Kingdom
Organization
AstraZeneca PLC
NYSE: AZN · Cambridge, United Kingdom
Organization
Autolus Therapeutics plc American Depositary Share
Nasdaq: AUTL · London, United Kingdom
Organization
Questions about Neurentis PLC
How many directors are on Neurentis PLC's board?
Neurentis PLC's board has 3 directors: Bijoy Kumar Premi, Dimitri Dimitriou and Stephane Robert Georges, Mery.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="neurentis-plc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.